查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球诊断成像市场 - 2023-2030 年
市场调查报告书
商品编码
1319150

全球诊断成像市场 - 2023-2030 年

Global Diagnostic Imaging Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

全球诊断成像市场规模在 2022 年达到 274 亿美元，预计到 2030 年将达到 416 亿美元，预测期内（2023-2030 年）的复合年增长率为 5.5%。慢性病和病理疾病患者人数的不断增加提高了对先进医学成像程序的需求。

对能及早发现病情的诊断设备的需求不断增加，推动了先进医疗成像设备市场的发展。随着技术的进步，图像检查后所需的报告时间也大大缩短。随着技术的升级，成像设备的精确度和准确性也得到了提高。

市场动态

越来越多的产品获批推动了诊断成像市场的增长

预计在预测期内，不断增长的市场发展将推动全球医学成像市场的增长。例如，2022 年 4 月，Wipro GE Healthcare 推出了新一代 Revolution Aspire CT 扫描仪。Revolution Aspire 是一种先进的成像解决方案，在印度进行端到端开发和制造。

此外，在 2023 年 2 月举行的第 75 届印度放射和成像协会（IRIA）全国大会上，医疗成像和信息系统领域的前沿企业富士胶片印度公司扩大了其产品和解决方案组合。新产品包括超声系统 Arietta 850 DeepInsight 和 Arietta 650 DeepInsight 以及新型核磁共振成像仪 APERTO Lucent Non-DICOM 打印机 APEOS。此外，该公司还推出了服务与支持移动应用程序 "FUJIFILM Connect"。

研究经费的增加有望为全球诊断成像市场带来增长机会

不断增加的研究经费有望在未来几年为全球诊断成像市场带来发展机会。例如，R&E 基金会的任务是通过设计研究人员和帮助终身的独创性调查和教育来资助放射学的未来。自 1984 年成立以来，该基金会已发放了 1,600 多笔赠款。这为放射学研究和加强患者护理提供了 7000 万美元的资金。

预计在预测期内，熟练人员和高效培训计划的短缺将阻碍全球诊断成像市场的发展

训练有素的人员短缺是诊断成像行业面临的一大挑战。诊断成像是一个高度专业化的领域，需要专门的培训和专业知识，而技术熟练的人才日益短缺。

技术人才短缺的主要原因之一是缺乏对诊断成像教育和培训计划的投资。许多大专院校没有开设影像诊断专业课程，而且影像诊断培训课程数量有限。

COVID-19 影响分析

COVID-19 在全球多个国家的流行和封锁影响了各行各业公司的财务健康。因此，在 COVID-19 公共卫生紧急事件期间，美国食品和药物管理局 (FDA) 发布了指导方针，其中包括帮助申办者和研究人员的一般注意事项，以确保试验参与者的安全、遵守良好临床实践 (GCP)，并将试验完整性的风险降至最低。

俄乌战争影响分析

俄乌冲突被认为对全球诊断成像市场的影响不大，因为该地区缺乏主要的市场参与者。乌克兰诊所虽然继续忍受俄罗斯军队的入侵，但迫于不断增加的死亡人数和有限的医疗援助。所有类型的医疗援助都出现短缺。同样，基础材料进出口的重要性预计将在预测期内对全球诊断成像市场的增长产生轻微影响。

目 录

第 1 章：研究方法与范围

  • 研究方法
  • 报告的研究目标和范围

第2章：定义和概述

第 3 章：执行摘要

  • 按类型分類的片段
  • 按应用分類的片段
  • 按最终用户分類的片段
  • 按地区划分

第四章：动态

  • 影响因素
    • 驱动因素
      • 市场日益发展
      • 慢性病发病率增长
    • 制约因素
      • 成本高昂
    • 机会
      • 研究经费不断增加
    • 影响分析

第 5 章：行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情况
    • COVID-19 期间的情景
    • COVID-19 后的情况
  • COVID-19 期间的定价动态
  • 供求关系
  • 大流行期间与市场相关的政府倡议
  • 制造商的战略倡议
  • 结论

第 7 章：按类型划分

  • X 射线
    • 模拟成像
    • 数字成像
  • 磁共振成像
    • 低场磁共振成像扫描仪
    • 高场磁共振成像扫描仪
    • 中场磁共振成像扫描仪
  • 核医学
    • 扫描
    • 正电子发射计算机断层显像
    • SPECT 成像
  • SPECT 成像
  • 超声波
    • 二维超声波
    • 三维/四维超声
    • 多普勒成像
  • 断层扫描
    • 高端 CT 扫描仪
    • 中端切片 CT 扫描仪
    • 低端切片 CT 扫描仪
  • 触觉成像
  • 功能性近红外光谱仪

第 8 章：按应用分类

  • 骨科
  • 神经科
  • 肿瘤学
  • 心脏病学
  • 其他应用

第 9 章：按最终用户分类

  • 医院
  • 诊断成像中心
  • 其他

第 10 章：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
      • 亚太其他地区
  • 中东和非洲
    • 特定地区的主要动态

第 11 章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併与收购分析

第十二章 ：公司简介

  • GE Healthcare
    • 公司概况
    • 产品组合和说明
    • 财务概况
    • 主要发展
  • Siemens Healthcare
  • Carestream Health Inc.
  • Hitachi Medical Corporation
  • Canon Toshiba Medical Systems Corporation
  • Hologic Corporation
  • Philips Healthcare
  • Fujifilm Holdings Corporation
  • Shimadzu Corporation
  • Mindray

第 13 章 ：附录

简介目录
Product Code: MI390

Market Overview

The Global Diagnostic Imaging Market reached US$ 27.4 billion in 2022 and is expected to reach US$ 41.6 billion by 2030, exhibiting a CAGR of 5.5% during the forecast period (2023-2030). The rising number of people with chronic diseases and pathological diseases has raised the need for avant-garde medical imaging procedures.

The rising need for diagnostic devices that can detect conditions earlier has increased the market for progressive medical imaging devices. With the improvement in technology, the reporting period which is needed after the image has been reviewed has also decreased extensively. The precision and accuracy of imaging devices have even improved with the upgrade in technology.

Market Dynamics

Increasing Product Approvals Drive the Growth of the Diagnostic Imaging Market

The increasing market developments are expected to boost the global medical imaging market growth in the forecast period. For instance, in April 2022, Wipro GE Healthcare introduced the next-generation Revolution Aspire CT scanner. Revolution Aspire is an advanced imaging solution developed and fabricated end-to-end in India.

Moreover, in February 2023, FUJIFILM India, a frontier in healthcare imaging and information systems, expanded its product and solutions portfolio at the 75th National Conference of the Indian Radiological and Imaging Association (IRIA). The new range possesses ultrasound system Arietta 850 DeepInsight and Arietta 650 DeepInsight along with the new MRI machine APERTO Lucent Non-DICOM printer APEOS. Further, the corporation even presented "FUJIFILM Connect" a service & support mobile application.

The Increase in Research Funding is Expected to Present the Global Diagnostic Imaging Market with Growth Opportunities

The increasing research funding is expected to present the global diagnostic imaging market with prospective growth opportunities in the upcoming years. For instance, the assignment of the R&E Foundation is to fund the future of radiology by designing researchers and helping lifelong ingenious investigation and education. Since the Foundation's beginning in 1984, it has granted more than 1,600 grants. That's $70 million in funding for radiology investigation and enhancing patient care.

The Shortage of Skilled Personnel and Efficient Training Programs is Estimated to Hamper the Global Diagnostic Imaging Market During the Forecast Period

The shortage of trained personnel is a considerable challenge facing the diagnostic imaging industry. Diagnostic imaging is a highly specialized field requiring specialized training and expertise, and there is a growing shortage of skilled personnel.

One of the primary reasons for the shortage of skilled personnel is the lack of investment in education and training programs for diagnostic imaging. Many universities and colleges do not offer specialized programs in diagnostic imaging, and there is a limited number of training programs available for diagnostic imaging.

COVID-19 Impact Analysis

The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, for the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is thought to hold a moderate influence on the global diagnostic imaging market, as there is a lack of primary market players in this region. Though continuing to countenance invasions from Russian armies, Ukrainian clinics are forced by growing numbers of deaths and limited medical aid. There are shortages across all types of healthcare assistance. Again, the significance of the import and export of fundamental materials are expected to slightly impact the global diagnostic imaging market growth in the forecast period.

Segment Analysis

The global diagnostic imaging market is segmented based on product type, disease type, end-user, and region.

The Tomography Type of Diagnostic Imaging is Estimated to Dominate the Global Diagnostic Imaging Market

The tomography type of diagnostic imaging is expected to hold around 37.8% of the global market share owing to the increasing product introductions into the market. For instance, in May 2023, Royal Philips, a multinational leader in health technology, launched the Philips CT 3500, a new high-throughput CT system targeting the requirements of everyday radiology and high-volume screening schedules.

Powered by AI, the Philips CT 3500 includes a range of image-reconstruction and workflow-enhancing characteristics that aid to provide the consistency, rate, and first-time-right image grade ought for assured diagnoses by clinicians and improved recovery on investment in the highly selective, high-volume care environments.

Moreover, in March 2022, at the 74th National Conference, IRIA 2022, Bengaluru, Siemens Healthineers introduced its latest product MAGNETOM Free. Star and NAEOTOM Alpha in MRI and CT pipeline. These product takeoffs supported the corporation broaden its consumer ground by delivering state-of-the-art medical imaging technology.

Geographical Analysis

Europe is Estimated to Hold 28.6% of the Market Share Owing to the Increasing Chronic Diseases Prevalence in this Region

Owing to the increasing cases of chronic diseases in this region, Europe is estimated to dominate the global market holding around 28.6% of the market by 2030. For instnace, according to the European Heart Network AISBL, annually cardiovascular conditions (CVD) causes 3.9 million casualties in Europe and more than 1.8 million deaths in the European Union (EU), CVD makes up for over 45% of all deaths in Europe and 37% of all deaths in the EU.

CVD is the primary reason for death in males in all whereas 12 nations of Europe and is the primary reason for death in females in all but two countries. Death rates from both ischaemic heart disease (IHD) and stroke are typically more increased in Central and Eastern Europe compared to Northern, Southern, and Western Europe.

Competitive Landscape

The major global players in the diagnostic imaging market include: GE Healthcare, Siemens Healthcare, Carestream Health Inc., Hitachi Medical Corporation, Canon Toshiba Medical Systems Corporation, Hologic Corporation, Philips Healthcare, Fujifilm Holdings Corporation, and Shimadzu Corporation, among others.

Why Purchase the Report?

  • To visualize the global diagnostic imaging market segmentation based on type, application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of diagnostic imaging market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available in excel consisting of key products of all the major players.

The global diagnostic imaging market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Market Developments
      • 4.1.1.2. Growing Incidences of Chronic Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost
    • 4.1.3. Opportunity
      • 4.1.3.1. Increasing Research Funding
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. X-Ray *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
      • 7.2.2.1. Analog Imaging
      • 7.2.2.2. Digital Imaging
  • 7.3. MRI
    • 7.3.1. Low-Field MRI Scanners
    • 7.3.2. High-Field MRI Scanners
    • 7.3.3. Mid-Field MRI Scanners
  • 7.4. Nuclear Medicine
    • 7.4.1. Scintigraphy
    • 7.4.2. PET Imaging
    • 7.4.3. SPECT Imaging
  • 7.5. SPECT Imaging
  • 7.6. Ultrasound
    • 7.6.1. 2D Ultrasound
    • 7.6.2. 3D/4D Ultrasound
    • 7.6.3. Doppler Imaging
  • 7.7. Tomography
    • 7.7.1. High-End Slice CT Scanners
    • 7.7.2. Mid-End Slice CT Scanners
    • 7.7.3. Low-End Slice CT Scanners
  • 7.8. Tactile Imaging
  • 7.9. Functional near Infrared Spectroscopy

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Orthopedic *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Neurology
  • 8.4. Oncology
  • 8.5. Cardiology
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Diagnostics Imaging Centers
  • 9.4. Other

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan

Australia

      • 10.5.6.4. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. GE Healthcare *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Siemens Healthcare
  • 12.3. Carestream Health Inc.
  • 12.4. Hitachi Medical Corporation
  • 12.5. Canon Toshiba Medical Systems Corporation
  • 12.6. Hologic Corporation
  • 12.7. Philips Healthcare
  • 12.8. Fujifilm Holdings Corporation
  • 12.9. Shimadzu Corporation
  • 12.10. Mindray

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us